To include this story in your blog or website —
Science Centric (17 Mar 2011 19:29 GMT) - Sirolimus, a drug currently used to help prevent transplant rejection, can improve lung function and quality of life in individuals living with the lung disease lymphangioleiomyomatosis (LAM), according to the results of a new study sponsored and conducted in part by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health…
— copy and paste the formatted text using the form to the left.